Wealth Enhancement Advisory Services LLC Buys 32,093 Shares of Hyperfine, Inc. (NASDAQ:HYPR)

Wealth Enhancement Advisory Services LLC increased its stake in Hyperfine, Inc. (NASDAQ:HYPR) by 64.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 82,008 shares of the company’s stock after purchasing an additional 32,093 shares during the period. Wealth Enhancement Advisory Services LLC owned approximately 0.11% of Hyperfine worth $72,000 as of its most recent filing with the SEC.

Separately, Renaissance Technologies LLC grew its position in Hyperfine by 32.9% in the fourth quarter. Renaissance Technologies LLC now owns 212,300 shares of the company’s stock valued at $187,000 after acquiring an additional 52,500 shares during the last quarter. 15.03% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on HYPR shares. B. Riley reiterated a “buy” rating on shares of Hyperfine in a research report on Tuesday, June 3rd. Wells Fargo & Company decreased their target price on Hyperfine from $1.29 to $0.68 and set an “equal weight” rating on the stock in a research report on Wednesday, May 14th. Finally, Lake Street Capital started coverage on Hyperfine in a research report on Monday, March 24th. They issued a “buy” rating and a $1.50 target price on the stock.

Hyperfine Trading Down 0.1%

Shares of HYPR stock opened at $0.70 on Thursday. The business’s 50-day moving average price is $0.70 and its 200-day moving average price is $0.88. Hyperfine, Inc. has a 12 month low of $0.53 and a 12 month high of $1.90. The firm has a market capitalization of $54.42 million, a price-to-earnings ratio of -1.29 and a beta of 0.95.

Hyperfine (NASDAQ:HYPR) last announced its quarterly earnings results on Tuesday, May 13th. The company reported ($0.12) EPS for the quarter, meeting analysts’ consensus estimates of ($0.12). Hyperfine had a negative return on equity of 74.19% and a negative net margin of 343.42%. The firm had revenue of $2.14 million for the quarter, compared to analyst estimates of $2.82 million. On average, sell-side analysts predict that Hyperfine, Inc. will post -0.57 earnings per share for the current fiscal year.

Hyperfine Profile

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.